Assurance for patients, providers, and stakeholders
FACT accreditation helps providers consistently provide quality care to patients, making them confident that they're in good hands. Accredited programs are committed to continuously delivering safe and high-quality treatments.
From Start to Finish
Cover the entire lifecycle of a cellular therapy or cord blood product, from collection to administration.
Proven Processes
Get guidance on processes and procedures from expert inspectors and a supportive peer review.
Robust Infrastructure
Minimize risk with multidisciplinary support, chains of identity and custody, and adverse event management.
Accreditation has already helped hundreds of organizations provide better patient care
Maximize compliance and stakeholder acceptance
FACT Standards are developed by international committees of cellular therapy providers, with input from the public and from governmental agencies, donor registries, industry, and other important stakeholders. In fact, many clinical trial groups require accreditation for participation and many health payers use FACT accreditation as a factor for designating "Centers of Excellence" or reimbursement. U.S. News & World Report uses FACT accreditation as a criterion for its Best Hospitals and Best Pediatric Hospitals lists.
Increase confidence across the spectrum
From physicians to patients, virtually every stakeholder involved in cellular therapy manufacturing and administration has a reason to seek out FACT-accredited organizations.
Accredited Organizations
Receive support and gain efficiency in safely advancing cellular therapies and patients' access to them.
Patients and Families
Seek accredited programs for trusted health care and safe cellular therapy and cord blood products.
Referring Physicians
Rely on FACT accreditation to confidently send their patients to a cellular therapy provider.
Registries and Clinical Trial Groups
Utilize FACT accreditation as an external measure of quality.
Supply Chain Participants
Achieve smooth interactions with accredited organizations' processes.
Pharmaceutical Companies
Partner with accredited sites for consistent cell collection and therapy administration.
Global Manufacturers and Clients
Leverage FACT for consistency across regions.
Hospitals
Benefit from FACT Accreditation in U.S. News & World Report rankings.
Voices of FACT stakeholders
FACT is regularly recognized for the value it brings to cellular therapy. The following are just a few examples.
I think [FACT accreditation] is
going to give us a level of
confirmation in the community
to go forward.
— Ivan Borello, MD, quoted in the McKenssen Cell and Gene Therapy Report, 2025
[FACT accreditation] may offer substantial benefits to centers and governments. These include reducing human error and complications, minimizing redundant audits, discouraging medical tourism, and ultimately improving clinical outcomes.
— CH Gutierrez-Aguirre, et al, Transplantation and Cellular Therapy, 2025
